Effect of serine hydroxamate on phospholipid synthesis in Escherichia coli.
Serine hydroxamate, which inhibits the charging of seryl-transfer ribonucleic acid, reduced the synthesis of phospholipid and nucleic acids in Escherichia coli. This effect was analogous to depriving amino acid auxotrophs of their nutritional requirement and appears to be a manifestation of the stringent response shown by rel(+) strains of E. coli. Amino acid starvation (serine or methionine) alone or serine hydroxamate treatment alone results in 60 to 80% inhibition of lipid accumulation, 90% inhibition of ribonucleic acid accumulation, and an increase in guanosine tetraphosphate (ppGpp). These three effects were reversed by addition of chloramphenicol (CM). A combination of serine starvation and serine hydroxamate treatment resulted in inhibition of lipid and RNA accumulation as well as an increase in ppGpp, but the consequences of the double block were not reversed by CM. We conclude that a strong interrelationship exists among these processes and that CM acts to relax a stringent response by mechanisms other than interference with ppGpp formation. All species of phospholipid were affected by a stringent response evoked by amino acid starvation or addition of serine hydroxamate, but in all cases the synthesis of phosphatidylethanolamine was most severely inhibited. Serine hydroxamate was not incorporated into lipid but specifically caused phosphatidylserine accumulation. Serine starvation produced a dramatic alteration of the distribution of isotope incorporated into phospholipid, which resulted from the stringent response compounded with the limitation of a substrate for phosphatidylserine synthesis.
D000255:Adenosine Triphosphate / Q000378:metabolism; D002701:Chloramphenicol / Q000494:pharmacology; D002855:Chromatography, Thin Layer; D004926:Escherichia coli / Q000187:drug effects / Q000378:metabolism*; D004952:Esters / Q000494:pharmacology; D006150:Guanine Nucleotides / Q000378:metabolism; D006160:Guanosine Triphosphate / Q000378:metabolism; D006877:Hydroxamic Acids / Q000494:pharmacology*; D050356:Lipid Metabolism; D009154:Mutation; D010743:Phospholipids / Q000096:biosynthesis*; D010759:Phosphorus Isotopes; D012313:RNA / Q000378:metabolism; D012694:Serine / Q000494:pharmacology*; D013997:Time Factors; D014316:Tritium
D004952:Esters; D006150:Guanine Nucleotides; D006877:Hydroxamic Acids; D010743:Phospholipids; D010759:Phosphorus Isotopes; D014316:Tritium; D012694:Serine; D012313:RNA; D002701:Chloramphenicol; D006160:Guanosine Triphosphate; D000255:Adenosine Triphosphate